Pharma Is Back To Raising Drug Prices, But Increases Aren’t Quite As Eye-Popping As Industry Tries To Avoid Spotlight

"Clearly, more caution is in the air and many major multinationals such as Pfizer and Novartis, which found themselves making the headlines several months back, have yet to implement their January increases,” said Raymond James analyst Elliot Wilbur. President Donald Trump said on Wednesday that he expects drug prices to drop despite pharmaceutical companies lifting their self-imposed hiatus on price increases.

from Kaiser Health News http://bit.ly/2ArscVG